Rita Laeufle (IMAGE) ECOG-ACRIN Cancer Research Group Caption Rita Laeufle is chief medical officer at Oncolytics Biotech, Inc. developing peloreorep, an IV-delivered immuno-oncolytic virus, and collaborating with PrECOG, LLC on the BRACELET-1 (PrE0113) clinical trial that will evaluate peloreorep in metastatic breast cancer. Credit Supplied by Oncolytics Biotech, Inc. Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.